Intrinsic Value of S&P & Nasdaq Contact Us

Illumina, Inc. ILMN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
61/100
4/7 Pass
SharesGrow Intrinsic Value
$143.90
+10.4%
Analyst Price Target
$147.13
+12.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Illumina, Inc. (ILMN) trades at a trailing P/E of 22.4, forward P/E of 25.4. Trailing earnings yield is 4.47%, forward earnings yield 3.93%. PEG 2.03. Graham Number is $47.17.

Criteria proven by this page:

  • VALUE (66/100, Pass) — P/E is below market average (22.4); analyst target implies upside (+12.9%); earnings yield beats bond yields (4.47%).
  • PEG Ratio 2.03 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 4.47% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
  • Analyst consensus target $147.13 (+12.9% upside) — modest upside expected.

Overall SharesGrow Score: 61/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
61/100
SG Score
View full scorecard →
VALUE
66/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
76/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
70/100
→ Income

Valuation Snapshot — ILMN

Valuation Multiples
P/E (TTM)22.4
Forward P/E25.4
PEG Ratio2.03
Forward PEG2.03
P/B Ratio6.99
P/S Ratio4.38
EV/EBITDA13.8
Per Share Data
EPS (TTM)$5.56
Forward EPS (Est.)$5.13
Book Value / Share$17.80
Revenue / Share$28.38
FCF / Share$6.14
Yields & Fair Value
Earnings Yield4.47%
Forward Earnings Yield3.93%
Dividend Yield0.00%
Graham Number$47.17
SharesGrow IV$143.90 (+10.4%)
Analyst Target$147.13 (+12.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 39.5 -41.91 8.06 7.63 -
2017 42.7 0.74 10.90 11.27 -
2018 51.9 3.97 11.14 12.86 -
2019 46.8 2.19 10.16 13.23 -
2021 80.1 -2.31 11.19 16.22 -
2022 72.9 5.24 5.17 12.27 -
2023 -7.0 0.01 4.68 6.73 -
2023 -18.4 0.25 3.72 4.75 -
2024 -17.4 -3.75 8.95 4.86 -
2025 24.2 -0.14 7.56 4.74 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $3.13 $2.4B $462.65M 19.3%
2017 $4.91 $2.75B $726M 26.4%
2018 $5.54 $3.33B $826M 24.8%
2019 $6.72 $3.54B $1B 28.3%
2020 $4.43 $3.24B $656M 20.3%
2021 $5.05 $4.53B $762M 16.8%
2022 $-28.05 $4.58B $-4.4B -96.1%
2023 $-7.35 $4.5B $-1.16B -25.8%
2024 $-7.69 $4.37B $-1.22B -28%
2025 $5.44 $4.34B $850M 19.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.13 $5.10 – $5.19 $4.54B $4.51B – $4.58B 10
2027 $5.84 $5.55 – $6.09 $4.79B $4.76B – $4.85B 10
2028 $6.66 $6.27 – $7.63 $5.09B $5.09B – $5.09B 5
2029 $7.53 $7.40 – $7.65 $5.4B $5.33B – $5.47B 2
2030 $8.23 $8.09 – $8.36 $5.68B $5.61B – $5.76B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message